Compound Name (alphabetical) | Binding Targets | Enz. Inhib. Data | ITC Data | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM10304
| - Acetylcholinesterase
- Acyl-CoA: cholesterol acyltransferase (ACAT)
- Carboxylesterase 1
- Caspase-3
- Cholinesterase
- Chorismate mutase (MTB CM)
- Factor XIIa
- Human rhinovirus A protease
- Transthyretin
| 6 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - 1-methyl-2,3-dihydro-1H-indole-2,3-dione
- CHEMBL60569
- Isatin analog 8
- N‐methylindol‐2,3‐dione (Compound 2)
|
BDBM108110
| - Coagulation factor X
- Coagulation factor XI
- Complement C1s
- Factor XIIa
- Plasma kallikrein
- Plasminogen
- Tissue-type plasminogen activator
- Transcription initiation factor IIA
- Vitamin K-dependent protein C
| 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM108115
| - Coagulation factor X
- Coagulation factor XI
- Complement C1r subcomponent
- Complement C1s
- Factor XIIa
- Plasma kallikrein
- Plasminogen
- Transcription initiation factor IIA
- Vitamin K-dependent protein C
| 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM10844
| - Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 5 (CDK5)
- Dual specificty protein kinase CLK1
- Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
- Glycogen Synthase Kinase-3, beta
- Glycogen synthase kinase-3 beta
- NF-kappa-beta-inducing kinase (NF-kB)
- cAMP-Dependent Protein Kinase (PKA)
- cGMP-Dependent Protein Kinase
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - 4-(1H-indol-3-yl)pyrimidin-2-amine
- Meridianin G
|
BDBM11337
| - Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Collagenase
- Collagenase (ChC)
- Matrix Metalloproteinase-8 (MMP-8)
- Matrix metalloproteinase 12
- Matrix metalloproteinase-1 (MMP1)
- Stromelysin-1
| 11 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | - 2-[benzyl(4-methoxybenzene)sulfonamido]-N-hydroxypropanamide
- CHEMBL316169
- Hydroxamate 18
|
BDBM11611
| - β-Carbonic anhydrase 2 (CA 2)
- β-Carbonic anhydrase 3 (CA 3)
- Astrosclerin-3
- Carbonic Anhydrase (mtCA 1)
- Carbonic Anhydrase III
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - β-CA inhibitor, 10
- 4-Amino-3,5-dibromobenzenesulfonamide
- 4-amino-3,5-dibromobenzene-1-sulfonamide
- CHEMBL306195
- halogenosulfanilamide deriv. 12
|
BDBM119122
| - MurA (E. coli)
- MurB (E. coli)
- MurB (S. aureus)
- MurC
- MurC (S. aureus)
- MurD
- MurD (S. aureus)
- MurE
- MurE (E. coli)
| 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - MurA/B/C/D/E inhibitor (compound 67)
|
BDBM127657
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 30
- US9782415, Example 30
- US9796724, Example 30
|
BDBM127679
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 52
- US9782415, Example 52
- US9796724, Example 52
|
BDBM127718
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 91
- US9782415, Example 91
- US9796724, Example 91
|
BDBM127720
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 93
- US9782415, Example 93
- US9796724, Example 93
|
BDBM127725
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 98
- US9782415, Example 98
- US9796724, Example 98
|
BDBM127733
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 106
- US9782415, Example 106
- US9796724, Example 106
|
BDBM127741
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 114
- US9782415, Example 114
- US9796724, Example 114
|
BDBM127750
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 123
- US9782415, Example 123
- US9796724, Example 123
|
BDBM127751
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 124
- US9782415, Example 124
- US9796724, Example 124
|
BDBM127767
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 140
- US9782415, Example 140
- US9796724, Example 140
|
BDBM127817
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 190
- US9782415, Example 190
- US9796724, Example 190
|
BDBM127821
| - High affinity nerve growth factor receptor
- JAK1 (aa 866-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyk2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | - US8791123, 194
- US9782415, Example 194
- US9796724, Example 194
|
BDBM13080
| - ADAM17
- Collagenase
- Matrix Metalloproteinase-8 (MMP-8)
- Matrix metalloproteinase-1 (MMP1)
- Matrix metalloproteinase-12 (MMP12)
- Matrix metalloproteinase-14 (MMP14)
- Matrix metalloproteinase-7 (MMP7)
- Meprin A subunit beta
- Stromelysin-1
| 8 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - CGS 27023A Analog 3
- N-hydroxy-2-[(4-methoxybenzene)(2-methylpropyl)sulfonamido]acetamide
|
BDBM130909
| - BDNF/NT-3 growth factors receptor
- Hepatocyte growth factor receptor
- High affinity nerve growth factor receptor
- Insulin receptor
- Insulin-like growth factor I receptor
- NT-3 growth factor receptor
- Proto-oncogene tyrosine-protein kinase ROS
- Proto-oncogene tyrosine-protein kinase receptor Ret
- Serine/threonine-protein kinase receptor R3
| 0 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - US8822500, Stauro- sporine
|
BDBM135812
| - 3',5'-cyclic phosphodiesterase (PDE4D)
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10085990, Example 30
- US8853226, 30
- US9393245, 30
|
BDBM135813
| - 3',5'-cyclic phosphodiesterase (PDE4D)
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10085990, Example 32
- US8853226, 32
- US9393245, 32
|
BDBM135814
| - 3',5'-cyclic phosphodiesterase (PDE4D)
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10085990, Example 33
- US8853226, 33
- US9393245, 33
|
BDBM135815
| - 3',5'-cyclic phosphodiesterase (PDE4D)
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10085990, Example 51
- US8853226, 51
- US9393245, 51
|
BDBM135816
| - 3',5'-cyclic phosphodiesterase (PDE4D)
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10085990, Example 54
- US8853226, 54
- US9393245, 54
|
BDBM135817
| - 3',5'-cyclic phosphodiesterase (PDE4D)
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10085990, Example 84
- US8853226, 84
- US9393245, 84
|
BDBM135818
| - 3',5'-cyclic phosphodiesterase (PDE4D)
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10085990, Example 92
- US8853226, 92
- US9393245, 92
|
BDBM135820
| - 3',5'-cyclic phosphodiesterase (PDE4D)
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10085990, Example 115
- US8853226, 115
- US9393245, 115
|
BDBM135821
| - 3',5'-cyclic phosphodiesterase (PDE4D)
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10085990, Example 118
- US8853226, 118
- US9393245, 118
|
BDBM135824
| - 3',5'-cyclic phosphodiesterase (PDE4D)
- Lipopolysaccharide-induced tumor necrosis factor-alpha factor
- Phosphodiesterase 4 and 5 (PDE4 and PDE5)
- Tumor necrosis factor
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- phosphodiesterase 4B2
- phosphodiesterase 4D
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10085990, Example 127
- US8853226, 127
- US9393245, 127
|
BDBM13814
| - Protein-Tyrosine Phosphatase 1B (PTP1B)
- Protein-Tyrosine Phosphatase 1B (PTP1B) Mutant (G117E)
- Protein-Tyrosine Phosphatase 1B (PTP1B) Mutant (L119V)
- Protein-Tyrosine Phosphatase 1B (PTP1B) Mutant (M114V)
- Protein-Tyrosine Phosphatase 1B (PTP1B) Mutant (V113I)
- Protein-Tyrosine Phosphatase 1B (PTP1B) Mutant (V113L/M114V)
- Protein-tyrosine phosphatase 1B
- T-Cell Protein-Tyrosine Phosphatase (TCPTP) Mutant (V121L)
- Tyrosine-protein phosphatase non-receptor type 2
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - ({4-[(4E)-2-(1H-1,2,3-benzotriazol-1-yl)-2-[4-(methoxycarbonyl)phenyl]-5-phenylpent-4-en-1-yl]phenyl}difluoromethyl)phosphonic acid
- benzotriazole phenyldifluoromethylphosphonic acid compound 1
|
BDBM14142
| - Coagulation factor X
- Hepsin
- Plasminogen
- Thrombin and coagulation factor X
- Tissue-type plasminogen activator
- Trypsin
- Trypsin-1
- Urokinase (uPA) Mutant (S190A)
- Urokinase-type plasminogen activator
| 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 2-{5-[amino(iminiumyl)methyl]-1H-indol-2-yl}-6-phenylbenzen-1-olate
- 3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-1,1-BIPHENYL-2-OLATE)
- APC-8696
- CA-04
- CRA-8696
|
BDBM14152
| - Coagulation factor X
- Hepsin
- Plasminogen
- Thrombin and coagulation factor X
- Tissue-type plasminogen activator
- Trypsin
- Trypsin-1
- Urokinase (uPA) Mutant (S190A)
- Urokinase-type plasminogen activator
| 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 6-CHLORO-2-(2-HYDROXY-BIPHENYL-3-YL)-1H-INDOLE-5-CARBOXAMIDINE
- APC-10302
- CA-14
- CRA-10302
- {amino[6-chloro-2-(2-hydroxy-3-phenylphenyl)-1H-indol-5-yl]methylidene}azanium
|
BDBM14320
| - Beta-secretase 1
- Coagulation factor III/Factor VIIa (fVIIa)
- Nitric oxide synthase, brain
- Nitric oxide synthase, endothelial
- Nitric oxide synthase, inducible
- Trypsin
- Tryptase
- Tyrosine-protein kinase TEC
- Urokinase-type plasminogen activator
| 4 | 4 | 1 | 0 | 0 | 0 | 1 | 0 | - 1-amino-isoquinoline
- CHEMBL62083
- Fragment 17
- fragment 1 (J. med. chem.,50,1116)
- isoquinolin-1-amine
|
BDBM14333
| - Coagulation factor X
- Plasminogen
- Thrombin and coagulation factor X
- Tissue-type plasminogen activator
- Trypsin
- Trypsin-1
- Tryptase
- Urokinase (uPA) Mutant (S190A)
- Urokinase-type plasminogen activator
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 2-{5-[amino(iminiumyl)methyl]-6-fluoro-1H-1,3-benzodiazol-2-yl}-6-phenylbenzen-1-olate
- CA-09
- CRA-10818
|
BDBM14350
| - Coagulation factor X
- Hepsin
- Plasminogen
- Thrombin and coagulation factor X
- Tissue-type plasminogen activator
- Trypsin-1
- Tryptase
- Urokinase (uPA) Mutant (S190A)
- Urokinase-type plasminogen activator
| 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 2-{5-[amino(iminiumyl)methyl]-6-fluoro-1H-1,3-benzodiazol-2-yl}-6-{[(1S,2S)-2-methylcyclohexyl]oxy}benzen-1-olate
- CA-11
- CRA-11092
|
BDBM14480
| - Coagulation factor X
- Hepsin
- Plasminogen
- Thrombin and coagulation factor X
- Tissue-type plasminogen activator
- Trypsin-1
- Tryptase
- Urokinase (uPA) Mutant (S190A)
- Urokinase-type plasminogen activator
| 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - CA-22
- [amino({4-[(3-hydroxynaphthalene-2-)amido]phenyl}amino)methylidene]azanium
|
BDBM14714
| - Coagulation factor VII
- Coagulation factor X
- Plasma kallikrein
- Plasminogen
- Thrombin and coagulation factor X
- Tissue-type plasminogen activator
- Trypsin
- Urokinase-type plasminogen activator
- Vitamin K-dependent protein C
| 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - (2R)-N-[(3-aminobenzene)sulfonyl]-2-[(4-carbamimidoyl-3-hydroxyphenyl)amino]-2-(3,5-diethoxy-2-fluorophenyl)acetamide
- G17905
- R-4-[2-(3-aminobenzenesulfonylamino)-1-(3,5-diethoxy-2-fluorophenyl)-2-oxoethylamino]-2-hydroxy-benzamidine.TFA
|
BDBM148173
| - Beta-secretase 1
- Beta-secretase 2
- Cathepsin D
- Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C8
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Potassium voltage-gated channel subfamily H member 2
| 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM148176
| - Beta-secretase 1
- Beta-secretase 2
- Cathepsin D
- Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C8
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Potassium voltage-gated channel subfamily H member 2
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - US8962616, 22
- US8962616, 4
|
BDBM152692
| - Histone Deacetylase 10 (HDAC10)
- Histone deacetylase
- Histone deacetylase 1
- Histone deacetylase 11
- Histone deacetylase 2
- Histone deacetylase 3
- Histone deacetylase 6
- Histone deacetylase 8
- Histone deacetylase 8 (HDAC8)
| 0 | 11 | 0 | 0 | 0 |